Lloyd Park’s Amgen AMGN Stock Holding History

Lloyd Park’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,260	Closed	-$508K	–	56
2021 Q4	$508K	Buy	+2,260	New	+$477K	0.28%	77

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Lloyd Park's AMGN Position: Q1 2022 in Review

Lloyd Park sold out of Amgen (AMGN) in Q1 2022, closing a stake of 2,260 shares — an estimated $508K sold.

Lloyd Park first reported a position in AMGN in Q4 2021 and held it in 1 quarter. The position peaked at $508K in Q4 2021. 2,336 funds tracked by Wall St. Rank hold AMGN as of Q1 2022.

Lloyd Park reported no remaining Amgen position as of Q1 2022 after selling out during the quarter.
Lloyd Park sold 2,260 Amgen shares in Q1 2022, an estimated $508K.
Lloyd Park first reported a position in Amgen in Q4 2021 and held it in 1 quarter.
Lloyd Park's Amgen position peaked at $508K in Q4 2021.
2,336 funds tracked by Wall St. Rank held Amgen as of Q1 2022.

Based on Lloyd Park's 13F filing for Q1 2022, filed 3 May 2022.